The basic-helix-loop-helix-leucine zipper transcription factor MITF plays major roles in the development and physiology of vertebrate melanocytes and melanoma cells. It is regulated by post-translational modifications, including phosphorylation at serine-73, which based on in vitro experiments imparts on MITF an increased transcriptional activity paired with a decreased stability. Serine-73 is encoded by the alternatively spliced exon 2B, which is preferentially skipped in mice carrying a targeted serine-73-toalanine mutation. Here, we measured the relative abundance of exon 2B+ and exon 2B-RNAs in freshly isolated and FACS-sorted wild-type melanoblasts and melanocytes, and generated a series of knock-in mice allowing forced incorporation of either alanine, aspartate, or wild-type serine at position 73. None of these knock-in alleles, however, creates a striking pigmentation phenotype on its own, but differences between them can be revealed either by a general reduction of Mitf transcript levels or in heteroallelic combinations with extant Mitf mutations. In fact, compared with straight serine-73 knockin mice with their relative reduction of 2B+ Mitf, forced incorporation of alanine-73 leads to greater increases in MITF protein levels, melanoblast and melanocyte numbers, and extent of pigmentation in particular allelic combinations. These results underscore, in vivo, the importance of the link between alternative splicing and post-translational modifications and may bear on the recent observation that exon 2B skipping can be found in metastatic melanoma.
Abstract
The basic-helix-loop-helix-leucine zipper transcription factor MITF plays major roles in the development and physiology of vertebrate melanocytes and melanoma cells. It is regulated by post-translational modifications, including phosphorylation at serine-73, which based on in vitro experiments imparts on MITF an increased transcriptional activity paired with a decreased stability. Serine-73 is encoded by the alternatively spliced exon 2B, which is preferentially skipped in mice carrying a targeted serine-73-toalanine mutation. Here, we measured the relative abundance of exon 2B+ and exon 2B-RNAs in freshly isolated and FACS-sorted wild-type melanoblasts and melanocytes, and generated a series of knock-in mice allowing forced incorporation of either alanine, aspartate, or wild-type serine at position 73. None of these knock-in alleles, however, creates a striking pigmentation phenotype on its own, but differences between them can be revealed either by a general reduction of Mitf transcript levels or in heteroallelic combinations with extant Mitf mutations. In fact, compared with straight serine-73 knockin mice with their relative reduction of 2B+ Mitf, forced incorporation of alanine-73 leads to greater increases in MITF protein levels, melanoblast and melanocyte numbers, and extent of pigmentation in particular allelic combinations. These results underscore, in vivo, the importance of the link between alternative splicing and post-translational modifications and may bear on the recent observation that exon 2B skipping can be found in metastatic melanoma.
Alternative splicing and post-translational modifications are among the major mechanisms by which individual genes generate multiple protein products. In fact, modern sequencing technologies and proteomic analyses have shown that most if not all multi-exon pre-mRNAs give rise to alternatively spliced mature mRNAs (NILSEN and GRAVELEY 2010) and that posttranslational modifications modulate the activities of most eukaryotic proteins (MANN and JENSEN 2003) . In a simple sense, then, the two mechanisms are linked as posttranslational modifications depend on the presence of the particular exons encoding the modifiable residues or proteolytic cleavage sites. Here, we present a mouse model that allows us to probe this link in vivo by separately targeting a splice site and a codon for a biologically relevant phosphoacceptor site in the gene encoding the pigment cell transcription factor MITF. In fact, pigmentation is particularly suitable for such studies as it provides for an easily visible and highly sensitive read-out of gene function.
MITF, which stands for microphthalmia-associated transcription factor, plays a crucial role in the development and function of melanin-bearing pigment cells in skin, eye and inner organs (ARNHEITER 2010; ARNHEITER et al. 2006; HODGKINSON et al. 1993) . Its protein product is a basic helix-loop-helix-leucine zipper transcription factor that regulates target gene promoters by binding specific E box sequences as homodimers or heterodimers with the related proteins TFEB, TFE3 and TFEC (STRUB et al. 2011) . Mitf mutations have been found from zebrafish to man and their analyses have established that Mitf controls specification, proliferation, death, differentiation and stress responses of normal pigment cells and regulates migration, metastasis, and death of melanoma cells (ARNHEITER et al. 2006; HOEK and GODING 2010) .
In vitro experiments have shown that phosphorylation of MITF serine-73 increases the protein's transcriptional activity about three-fold (HEMESATH et al. 1998) and that serine-73 phosphorylation alone or double serine-73/serine-409 phosphorylation lead to polyubiquitination and degradation of MITF (WU et al. 2000; XU et al. 2000) . To address the question of whether serine-73 phosphorylation plays a role in vivo, we have previously generated targeted mice in which codon-73 was changed to one encoding alanine-73 which cannot be phosphorylated (BISMUTH et al. 2008) . These mice had a normally pigmented coat and normal eyes, a finding that was later confirmed by using a transgenic bacterial artificial chromosome (BAC) rescue strategy with BACs engineered to encode alanine-73 alone or alanine-73 and alanine-409 together (BAUER et al. 2009) . A complication of these experiments was the fact that the Mitf exon which encodes serine-73, exon 2, contains a 5' alternative splice site that divides it into an exon 2A of 20 codons and an exon 2B of 56 codons, the latter including codon-73. This arrangement normally leads to a major transcript (at least 90% of total Mitf RNA in skin or heart) that contains the entire exon 2, and a minor one in which exon 2B, and hence codon-73, is missing although the open reading frame is maintained (BAUER et al. 2009; BISMUTH et al. 2008) . Interestingly, the codon-73 mutation in both targeted mice and BAC transgenics is associated with a substantial decrease of the transcripts containing exon 2B (representing only ~10% of total Mitf mRNA in the targeted mice and ~45% in the BAC rescue mice), and a concomitant increase of the transcripts lacking exon 2B (BAUER et al. 2009; BISMUTH et al. 2008 ). This splice change, which is likely due to the fact that codon-73 is embedded in a splice enhancer sequence whose affinity for the serine/arginine rich splice regulator SRSF5 is reduced upon mutation (WANG et al. 2009 ), precluded meaningful conclusions on the specific role of serine-73. In order to separate the potential effects of mutations at residue 73 from the splice-dependent absence of this residue, we re-targeted Mitf in a way that renders the alternative 5' splice site non-functional and incorporates either a wild-type serine, a phosphomimetic aspartate, or an alanine at position 73. We find that although the new mutations cause no visible coat phenotypes on their own, they sensitize melanocytes to the phenotypic effects of reductions in total Mitf levels and to the effects of extant Mitf alleles in compound heterozygotes. Intriguingly, when tested under such conditions, the targeted allele containing the wild-type serine behaves as a hypomorph while that containing the alanine behaves as a hypermorph. The results show that alternative splicing of exon 2B is indeed relevant in vivo, although in an unexpected manner and in a way that would be difficult to detect based solely on in vitro experiments.
Material and Methods

Melanoblast/melanocyte purification and RNA-Seq data
Melanocytes were purified by FACS sorting from doxycycline-treated bi-transgenic mice (iDct-GFP mice, strain FVB/N) that express H2B-GFP fusion proteins specifically in Dctpositive melanocytes, using previously published protocols (ZAIDI et al. 2011a; ZAIDI et al. 2011b; ZAIDI et al. 2011c) . To purify melanoblasts from E15.5 and E17.5 C57BL/6 iDct-GFP embryos and P1 pups, the dams were fed doxycycline-fortified chow for the entire duration of gestation until harvest. For P3 and P7 pups, doxycycline was injected intraperitoneally at 80µg/g body weight 24 hours before harvest. Total RNA was prepared from FACS-sorted melanoblasts/melanocytes according to standard Illumina RNA-Seq paired-end protocol and sequenced on the Illumina GAIIx to 80 base pairs per read. For analysis of alternative exon 2B splicing, a set of possible splice sites was determined and assigned to the aligner, indicating that a given splice variant might exist.
The sequences were aligned using Genomic Short-Read Nucleotide Alignment Program (WU and NACU 2010) to mouse genome assembly mm9. A custom Python script was then used to count introns that had one boundary at position 97944374 on chromosome 6 (5' end of exon 3). The analysis revealed that only three splice sites were used, one at position 97943348, yielding 2B+ Mitf, one at position 97943180, yielding 2B-Mitf, and a single read for one at position 97879927, yielding Mitf with a junction between exon H and exon 3.
Targeting constructs, minigenes and expression plasmids
The 17.9 kb targeting construct described by Bismuth et al. (BISMUTH et al. 2008 ) was used as template to PCR-amplify a 1.2 kb EcoR1/HindIII-flanked fragment encompassing part of intron 1, exon2A/2B and part of intron2/Neo-loxP cassette. The PCR-amplified fragment was cloned into pcDNA 3.1 and used for PCR mutagenesis. In a first round, the exon 2A/2B junction was altered by changing 4 bases without changing the coding sequence. In a second round, the previously introduced ApaLI site was changed back to the wild-type sequence and codon A73 was either left intact or was changed into one encoding either aspartate or wild-type serine. Sequence-confirmed clones for each of the three different codons at residue 73 were digested with AflII and AgeI and used to replace the corresponding AflII/AgeI fragment in a 7.5 kb BamH1 fragment representing the 3' arm of the original construct. The resulting constructs were digested with BamH1 and ligated to a BamHI-linearized construct containing the thymidine kinase gene and the 5' arm of the original construct, yielding three final reengineered targeting constructs. The correct orientation of the 7.5 kb BamHI fragment was verified by PCR with 2 primer pairs described in Suppl. Table 1 . To test for the effect of the 5' splice junction mutation, an Mitf minigene comprising exon 1M, intron 1, exon 2A/B, intron 2 and exon 3 was subjected to PCR mutagenesis to alter the 5' splice junctions and codon-73 as in the targeting contructs, using Quickchange site-directed mutagenesis kit (Stratagene). For expression analysis, N-terminal estrogen-receptor (ER)-coupled Mitf 6a+ pBABE vectors were obtained from Colin Goding (CARREIRA et al. 2005 ) and subjected to PCR mutagenesis to obtain Mitf S73A (ER S73A) and Mitf ∆2B (ER 2B-) expression plasmids, using a primer set described in Suppl. The bi-transgenic iDct-GFP mice (ZAIDI et al. 2011a ) used for RNA-Seq were kept on a FVB/N background.
Reverse transcription, RT-PCR and Real-time (q)RT-PCR, western blots
Random primed cDNAs were made from 500 ng of total RNA extracted from heart or 50 ng extracted from melanocyte lines using High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) and RNAse inhibitor cocktail (Invitrogen). PCR and qPCR were performed as described (BHARTI et al. 2010) , using primers described in Suppl. Table 1 .
For western blots, 600 µ g of heart tissue or 120,000 cultured cells were separated by SDS-PAGE and blotted onto nitrocellulose membranes. The blots were exposed to appropriate antibodies and bands were revealed using SuperSignal West Pico Chemiluminiscent Substrate. Quantitation was done using a Biorad ChemiDoc XRS+ system.
Genotyping and Southern analysis
DNA extracted by standard procedures from tissue samples was analyzed by PCR, using primers indicated in Suppl. Table 1 . For Southern blots, liver DNA was prepared, digested as indicated and probed using PCR-amplified probes as previously published (BISMUTH et al. 2008) .
Photography
Photographs of knock-in mice and their intercrosses with other Mitf alleles were taken between 3 weeks and 2 months of age. 
Cell lines stably expressing Mitf proteins
2008).
Flow cytometry
For assaying MITF expression, ARPE19 cells were washed and fixed with 4%
paraformaldehyde, permeabilized and incubated with mouse monoclonal antibody 6A5
and R-phycoerythrin-goat anti-mouse IgG1 as second antibody. Flow cytometry was performed using a FACSVantage SE flow cytometer (Becton Dickinson) and the data processed using CellQuest software. The gating was determined empirically and applied in the same way to all experiments.
Results
Alternative splicing of exon 2B of Mitf in melanocytes
Previous results have shown that heart and skin of wild-type mice express Mitf splice variants that specifically lack exon 2B (BAUER et al. 2009; BISMUTH et al. 2008; HALLSSON et al. 2000) . To confirm these findings in freshly isolated embryonic and postnatal melanocytes, we purified the respective cells by FACS, using the recently described bi-transgenic iDct-GFP mice that allow for tetracyclin-regulated expression of a histone H2B-GFP fusion protein in melanoblasts and melanocytes (ZAIDI et al. 2011a; ZAIDI et al. 2011b; ZAIDI et al. 2011c) . For these experiments, we used wild-type embryos at E15.5, E17.5, and postnatal mice at P1, P3 and P7. RNA-Seq of sorted cells clearly showed the presence of Mitf RNA. As shown in Fig. 1A , detailed analyses revealed that although in all samples the majority of reads across the 5' alternative splice junctions of exon 2 corresponded to the exon 2B-exon 3 sequence, a small subset corresponded to the exon 2A-exon 3 sequence. To further confirm these results, we subjected RNA from P1 and P3 FACS-sorted cells to real-time RT-PCR as described (BHARTI et al. 2008) . The results showed a 2B-/(2B-+ 2B+) ratio of between 1.85 and 4.36%. These values were similar to those in passage 10 melanocytes obtained from P2 mice that were wild-type at Mitf and homozygous for a Cdkn2a targeted null allele used to prevent cell senescence (SVIDERSKAYA et al. 2002) (Fig. 1B) . In contrast, in corresponding melanocytes from P2 skin of Mitf-S73A mutated, Cdkn2a -/-mice (labeled S73A in Fig. 1B ), the ratio was 90.75%. These results indicate that freshly isolated embryonic or postnatal melanocytes or cultured melanocytes express a small amount of Mitf mRNAs lacking exon 2B and that a serine-73 mutation substantially increases this alternatively spliced transcript.
A targeted mutation in the exon 2A/2B junction of Mitf prevents exclusion of exon 2B in vitro and in vivo
As shown in Fig. 2A and Suppl. Fig. 1 , the RNA sequence of the alternative 5' splice site, CACCAG'GUAAAG, is close to the consensus splice sequence, C/AAG'GUA/GAGU. To ensure efficient inclusion of exon 2B despite codon-73 mutations, we deliberately mutated this splice site in genomic DNA to yield RNAs with the sequence CAUCAA'GUUAAA. The mutation was expected to render the 5' splice junction non-functional without, however, changing the encoded aminoacid sequence.
We first tested whether the mutation would function in the intended way in a minigene construct that comprised exon 1M-exon 3 of Mitf. Upon transfection into heterologous cells, this construct normally recapitulates the alternative exon 2B splicing and its dependence on the sequence of codon-73. When both the 5' splice junction and codon-73 were mutated, however, only exon 2B+ RNA and no aberrant splice products were produced in vitro (not shown). We then prepared 3 separate targeting constructs that carried the same splice mutation along with a codon for either wild-type serine, aspartate, or alanine ( Fig Together with Mitf mi-S73A mice, which do not carry the 5' splice site mutation, we established eight separate lines, four of them containing a floxed neomycin resistance cassette in intron 2 (see Fig. 2A ), and four corresponding ones in which this cassette was removed by breeding with Prm1-Cre deleter mice.
For RNA analyses, we first used heart tissue because heart expresses relatively high levels of Mitf RNA and, unlike melanocytes, is not altered in a major way by Mitf quantitative RT-PCR analyses using primers for exon 6-7 and 8-9 (Suppl. Table 1) , were similar to wild type in the mutants in which the neo cassette has been removed (Suppl. To determine RNA and protein expression specifically in melanocytes, we then (Fig. 4F ,G,I,J). In contrast, no such differences between the targeted alleles were seen in combination with Mitf Mi-wh as all mice had a fawn coat with white spots of similar sizes (Suppl. Figure 2A ). Only rarely did we observe small black spots in these mice that may reflect somatic loss-of-function mutations in the dominant-negative Mitf Mi-wh allele (an example shown in Suppl. Fig. 2A for Mitf
Mi-wh ). We also saw no major codon-73-dependent differences in combinations
with Mitf mi as all mice were totally white except for small black spots that appeared in highest frequency and sizes in Mitf mi-S-S73ANeo /Mitf mi mice but were always absent in Mitf mi-S-S73SNeo /Mitf mi mice (Suppl. Fig. 2B ). These results indicate that in alleles containing the neomycin resistance cassette, the presence or absence of exon 2B and the phosphorylatability or permanent negative charge of residue-73 are associated with phenotypic differences that are, however, only seen in particular allelic combinations.
In a second round of breedings, we used mice lacking the neomycin cassette to generate targeted homozygotes or compound heterozygotes as above. As shown in Fig.   4K -N, homozygotes were all normally pigmented regardless of the splice and serine-73 mutations. In contrast, phenotypic differences between the different targeted Mitf alleles were seen in combination with Mitf Mi-wh ( Fig. 4O-R allele in some allelic combinations leads to decreased sizes of white spots (or increased numbers of pigmented spots) compared to mice carrying the S73A allele (see Fig. 4A,B; F,G; Suppl. Fig 2B) .
Because Mitf mi-S73A is a complex allele, giving rise to both exon 2B-as well as exon 2B+ protein (see Fig. 3G and ER 2B-in Fig. 6 ). In such cells, MITF proteins normally are found in the cytoplasm at relatively low levels but accumulate at high levels in nuclei after tamoxifen induction.
In fact, western blots revealed the expected MITF bands and electrophoretic mobilities after tamoxifen induction (Fig. 6A) . The cells were then subjected to flow cytometry, using two-color fluorescence labeling for MITF protein expression and total DNA content (DAPI) for cell cycle analysis. As shown in Fig. 6B 
Discussion
Numerous in vitro assays have shown that MITF is regulated by post-translational modifications, which in turn depend on the presence of the exons carrying the modifiable residues. Nevertheless, among the many spontaneous and induced Mitf mutations from zebrafish to man, few have been found so far to affect splicing or a specific posttranslationally modifiable residue. This is not surprising given the fact that, for instance, targeted mutations in the serine-73 phosphoacceptor site as described here, along with those used in BAC transgenic rescue strategies (BAUER et al. 2009 ), produce little if any phenotypes on their own. It is only in conjunction with additional perturbations, such as the reduction in overall Mitf RNA levels or the combination with other Mitf alleles, that we start to see the effects of mutations in serine-73, or, in addition, the subtle differences between a serine-73 mutation and the lack of the entire exon carrying serine-73. Genomic modifications of 4 Mitf knock-in alleles Mitf 5'-CAGGGCTCAGAGGCACTACT-3' F 5'-GCTCCCTCCCTGCAATACTT-3' R qPCR USF1
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